Omega Protein Reports Received Letter from Holder, Wynnefield Capital

Loading...
Loading...
Omega Protein Corporation
OME
, a nutritional product company and a leading integrated provider of specialty oils, essential fatty acids and specialty protein products, acknowledged today that it has received a letter from a shareholder, Wynnefield Capital Management, LLC that was filed as an exhibit to a Schedule 13D filing made by that shareholder with the Securities and Exchange Commission. Omega Protein's Chairman of the Board, Gary R. Goodwin, stated, "The Board of Directors values open dialogue and input from all our shareholders. While we believe the company's current strategy will create substantial long-term value for shareholders, we will thoughtfully review the matters raised by Wynnefield Capital. The Board and management team are committed to undertaking actions that we believe will enhance value for our shareholders, and we intend to consider this letter with that principle in mind."
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...